Search Browse Earnings

PAVmed Inc.

Nasdaq:PAVM

Surgical & Medical Instruments & Apparatus·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

PAVmed Inc. — SlamSEC

Revenue

$2.5M

+550.4% YoY

FY 2024

Adj. EBITDA

-$65.9M

-2686.1% margin

FY 2024

Net Income

-$64.2M

-2617.3% margin

FY 2024

EPS (Diluted)

-$9.16

FY 2024

Stock Price

$10.63

+2.0%

2026-03-09

52W Range

$6.00 – $28.44

P/E Ratio

-1.2x

Market Cap

$122.5M

Cash

$19.6M

FY 2024

Total Debt

$300,000

FY 2021

Net Cash

$19.3M

FY 2021

Enterprise Value

$103.2M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-1.6x

Employees

—

CEO

Aklog Lishan

CFO

Mcgrath Dennis M